HUTCHMED DRC (HCM) financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $2.3B

HUTCHMED DRC reported revenue of $549M in fiscal 2025, up 10.9% a year over 9 years.

Net income was $457M and the operating margin -7.1%, against -21.6% in 2016.

Free cash flow was -$79M.

The diluted share count rose 46% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.500.512016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from HUTCHMED DRC's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$216M$241M$214M$205M$228M$356M$426M$838M$630M$549M
Cost of revenue$149M$170M————$311M$384M$349M$336M
Gross profit$67M$71M————$115M$454M$281M$212M
Research and development$67M$76M$114M$138M$175M$299M$387M$302M$212M$148M
Selling, general and admin$40M$43M$49M$53M$61M$127M$136M$133M$113M$103M
Operating income-$47M-$53M-$93M-$146M-$197M-$328M-$408M$18M-$44M-$39M
Interest expense$2M$1M$1M$1M$787,000$592,000$652,000$759,000$3M$3M
Pre-tax income$21M-$54M-$87M-$141M-$190M-$216M-$410M$58M-$1M$499M
Income tax$4M$3M$4M$3M$5M$12M-$283,000$5M$7M$64M
Net income$12M-$27M-$75M-$106M-$126M-$195M-$361M$101M$38M$457M
EPS (diluted)$0.02-$0.04-$0.11-$0.16-$0.18-$0.25-$0.43$0.12$0.04$0.52
Diluted shares600M617M664M666M698M793M847M869M873M873M
Gross margin31.0%29.6%————27.0%54.1%44.6%38.7%
Operating margin-21.6%-22.1%-43.3%-71.4%-86.3%-92.2%-95.6%2.2%-6.9%-7.1%
Net margin5.4%-11.1%-34.9%-51.7%-55.2%-54.7%-84.6%12.0%6.0%83.3%

Balance sheet

Fiscal years, from HUTCHMED DRC's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$104M$358M$301M$217M$435M$1.0B$631M$886M$836M$1.4B
Receivables$41M$38M$40M$41M$48M$84M$98M$117M$156M$127M
Inventory$13M$12M$12M$16M$20M$36M$57M$50M$50M$41M
Total current assets$167M$432M$371M$317M$531M$1.2B$840M$1.1B$1.1B$1.6B
Property, plant and equipment$10M$14M$17M$21M$24M$41M$76M$100M$92M$95M
Goodwill$3M$3M$3M$3M$3M$3M$3M$3M$3M$3M
Total assets$342M$598M$532M$465M$724M$1.4B$1.0B$1.3B$1.3B$1.8B
Total current liabilities$95M$105M$85M$113M$158M$312M$354M$403M$377M$316M
Long-term debt$27M—$27M$27M$27M—$18M$48M$59M$68M
Total liabilities$138M$113M$120M$152M$205M$333M$393M$536M$502M$502M
Shareholders' equity$184M$462M$389M$288M$484M$987M$610M$731M$760M$1.2B
Net debt-$33M-$55M-$59M-$94M-$209M-$351M-$295M-$204M-$71M$22M

Cash flow

Fiscal years, from HUTCHMED DRC's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow-$10M-$9M-$33M-$81M-$62M-$204M-$269M$219M$497,000-$65M
Capital spending$4M$5M$6M$9M$8M$16M$37M$33M$18M$14M
Free cash flow-$14M-$14M-$39M-$89M-$70M-$221M-$305M$187M-$17M-$79M
Share buybacks (net)-$604,000-$1M-$5M-$346,000-$13M-$27M-$48M-$9M-$36M—
Free cash flow margin-6.4%-5.8%-18.3%-43.7%-30.7%-62.0%-71.6%22.3%-2.8%-14.4%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for HCM.
Open HCM in Investingly

Questions

What was HUTCHMED DRC's revenue in 2025?

$549M in fiscal 2025, from its 10-K filing.

How much free cash flow does HUTCHMED DRC generate?

-$79M in fiscal 2025 (operating cash flow minus capital spending).

From HUTCHMED DRC's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.